NEA Management Company’s Supernus Pharmaceuticals SUPN Stock Holding History

NEA Management Company’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,641,250	Closed	-$107M	–	35
2015 Q3	$107M	Hold	7,641,250	–	–	7.06%	4
2015 Q2	$130M	Sell	7,641,250 -3,008,750	-28%	-$42.8M	6.78%	4
2015 Q1	$129M	Hold	10,650,000	–	–	5.82%	4
2014 Q4	$88.4M	Hold	10,650,000	–	–	4.29%	8
2014 Q3	$92.5M	Hold	10,650,000	–	–	4.7%	8
2014 Q2	$116M	Hold	10,650,000	–	–	5.42%	6
2014 Q1	$95.2M	Hold	10,650,000	–	–	4.67%	7
2013 Q4	$80.3M	Hold	10,650,000	–	–	3.88%	6
2013 Q3	$78.1M	Hold	10,650,000	–	–	3.09%	9
2013 Q2	$68.5M	Buy	+10,650,000	New	+$62.7M	3.06%	9

Other funds holding SUPN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NEA Management Company's SUPN Position: Q4 2015 in Review

NEA Management Company sold out of Supernus Pharmaceuticals (SUPN) in Q4 2015, closing a stake of 7,641,250 shares — an estimated $107M sold.

NEA Management Company first reported a position in SUPN in Q2 2013 and held it in 10 quarters. The position peaked at $130M in Q2 2015. 210 funds tracked by Wall St. Rank hold SUPN as of Q4 2015.

NEA Management Company reported no remaining Supernus Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
NEA Management Company sold 7,641,250 Supernus Pharmaceuticals shares in Q4 2015, an estimated $107M.
NEA Management Company first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 10 quarters.
NEA Management Company's Supernus Pharmaceuticals position peaked at $130M in Q2 2015.
210 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2015.

Based on NEA Management Company's 13F filing for Q4 2015, filed 22 Jan 2016.